Slides
Page 1
First Half 2026 ResultsSOL Group
Page 2
2 SOL GROUP | RevenuesSales development (H1 2026) International Sales development [M€] 658,2735,7779,6874,1948,601002003004005006007008009001.000 Jun-22 Jun-23 Jun-24 Jun-25 Jun-26 +9,6% CAGR+8,5% 62,0%38,0% 52,6%HomeCare47,4%Technical GasesOther CountriesItaly +5,5%vs previous year +9,1%vs previous year+7,7%vs previous year +11,3%vs previous year + 7,2 % organic growth+ 1,6 % M&A- 0,3 % FX effect June 2026 vs June 2025> 8.000 employees
Page 3
3 SOL GROUP | ResultsEBITDA and EBIT (H1 2026) International EBITDA [M€] & Margin [%] EBIT [M€] & Margin [%] 157,8193,6201,3220,8247,4 050100150200250 Jun-22 Jun-23 Jun-24 Jun-25 Jun-26 +12,1%92,8118,9122,2134,9148,8 0102030405060708090100110120130140150 Jun-22 Jun-23 Jun-24 Jun-25 Jun-26 +10,3% 26,3%25,8%25,3%26,1%16,2%15,7%15,4%15,7%24,0%14,1%
Page 4
4 81,1107,3104,9107,4123,2 0102030405060708090100110120130 Jun-22 Jun-23 Jun-24 Jun-25 Jun-2625,9%25,9%24,1%26,2% SOL | Technical GasesRevenues (H1 2026) Sales development [M€]EBITDA [M€] & Margin [%] 410420430440450460470480 20 490 390 500 400Jun-23 Jun-24 Jun-25 Jun-26382,2414,1405,6444,9469,5 Jun-22 +5,5% 21,2%
Page 5
5 SOL | Technical GasesIndustrial Production
Page 6
6 VIVISOL | Home CareRevenues (H1 2026) Sales development [M€]EBITDA [M€] & Margin [%] 3003500400450500 Jun-22 Jun-23 Jun-24 Jun-25 Jun-26 391,9449,2 294,6 499,8 339,0 +11,3%76,786,496,4113,4124,2 0102030405060708090100110120130 Jun-22 Jun-23 Jun-24 Jun-25 Jun-26933.000 patientsvs +12,9%previous year26,0%25,5%24,6%25,2%24,8%
Page 7
7 SOL GROUP | RatiosInvestments and Net Profit (H1 2026)Net Profit of the YearCAPEX of the year (excl. M&A) 64,779,674,983,589,9 0102030405060708090 Jun-22 Jun-23 Jun-24 Jun-25 Jun-26 +7,6%Net Result of the Period 0102030405060708090100110120130 Jun-22 Jun-23 Jun-24 Jun-25 Jun-2661,593,3104,7125,0113,6-9,1%Group Intangible AssetsTechnical Gases Tangible AssetsHome Care Tangible Assets 9,8%10,8%9,6% 9,6%9,5% Net Result of the Period %
Page 8
8 SOL GROUP | RatiosNet Financial Position (2026)Net Financial Position & Cash Flow Cover 1,191,09 1,091,071,180,70,80,91,01,11,21,31,41,51,61,71,81,92,02,12,2 050100150200250300350400450500550600 Dec-22 Dec-23 Dec-24 Dec-25 Jun-26 389,7415,8439,3484,3562,5 Net Debt/EBITDANet Financial Position (IFRS16)Net Financial Position (No IFRS16)* * Net Debt/EBITDA index is evaluated on MAT (Moving Annual Total) along the year
Page 9
9 SOL GROUP | Seizing opportunities despite difficult contextsMergers and acquisitions (2026)SWITZERLAND – Home CareREINFORCEMENTthrough VITALAIRE Leader in home respiratory care provider serving over 6,000 patients with advanced services in sleep apnea, mechanical ventilation, and oxygen therapy. ITALY – Home CareDIVERSIFICATIONthroughHAEMOPHARM BIOFLUIDS Founded in 2002 and acquired by Medtronic/Mozarc Medical Group in 2016, Haemopharm Biofluids manufactures infusion drugs and dialysis solutions in Tovo di Sant’Agata (Sondrio). BRAZIL – Home CareREINFORCEMENT of presence through OXYGENAR Brazilian home care provider founded over 15 years ago by CEO Ivan Vitor Machado da Silva. Following its rapid growth across Rio de Janeiro, São Paulo, and the acquisition of Pulmonair, Oxigenar now operates a network of 24 sleep centers dedicated to personalized oxygen therapy, sleep apnea, and mechanical ventilation services. UK – Home CareDIVERSIFICATIONthrough REMEO Center of excellence for complex mechanical ventilation, following the renowned rehabilitation-focused "Lane Fox" clinical model to support long-term patients outside of intensive care.
Page 10
10 SOL GROUP | Seizing opportunities despite difficult contextsMergers and acquisitions (2026) - IBGIBJV Participações Ltda (SOL Group)51%Mr. Newton de Oliveira49%Industria Brasileira de Gases S.A. (IBG)- € 35 millions gross revenues- 258 employees-4 Air Separation Units+ 1 Under Construction- 3 CO2 plants
Page 11
11 Title presentation SOL GROUP | Seizing opportunities despite difficult contextsMergers and acquisitions (2026) – Nowus Healthcare- € 6,9 million revenues- 14 employeesNowusHealthcare A/S100%
Page 12
solgroup.com